Title : Vandetanib for the treatment of non-small-cell lung cancer.

Pub. Date : 2011 Oct

PMID : 21819274






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib is an orally available inhibitor of VEGFR and EGFR signalling and is an attractive therapeutic agent owing to the simultaneous inhibition of both pathways. vandetanib epidermal growth factor receptor Homo sapiens